Health Catalyst, Inc. (HCAT) stock
Close on Nov 12, 2026Market cap $102.35MP/E –Yield –
Health Catalyst, Inc. saw revenue fall 13.9% to $272.21M over the twelve months to Sep 30, 2026. Free cash flow was $25.71M. At the latest close the market valued the company at $102.35M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $102.35M
- P/E ratio
- –
- Price to sales
- 0.38
- Price to book
- 0.70
- Dividend yield
- –
- Free cash flow yield
- 25.12%
Fundamentals
- Revenue
- $272.21M
- Net income
- -$202.09M
- EPS, diluted
- -$2.83
- Free cash flow
- $25.71M
- Book value per share
- $1.92
- Diluted shares
- 76M
Trading
- Next earnings
- Mar 11, 2027 (estimated, after the close)
- Previous close
- $1.43
- Open
- $1.46
- Day's range
- $1.34 – $1.48
- Volume
- 686,699
- Average volume (20 days)
- 348,183
- Beta (5 years)
- 1.82
- 52-week range
- $0.96 – $3.02
- RSI (14 days)
- 34.9
- Volatility (1 year)
- 91.8%
- Relative volume
- 1.21×
- WACC
- 14.0%
On 2 of our idea lists: More cash than they're worth, Insiders buying the dip
Market cap history
Month-end market cap since 2019, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | HCAT | S&P 500 | Difference | HCAT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -22.3% | -2.7% | −19.6 pts | ||
| 3 months | -24.0% | -1.7% | −22.3 pts | ||
| Year to date | -43.1% | +11.9% | −55.0 pts | ||
| 1 year | -44.7% | +12.0% | −56.7 pts | ||
| 3 years | -79.7% | +78.2% | −157.9 pts | -41.3% | +21.2% |
| 5 years | -97.2% | +73.2% | −170.4 pts | -51.1% | +11.6% |
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Health Catalyst filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Results
- Results
About Health Catalyst
Services-Computer Programming, Data Processing, Etc.
Health Catalyst provides data and analytics technology alongside professional services to healthcare organizations. The company's primary solution integrates its proprietary cloud-based Ignite data platform with software applications and domain expertise. Its software applications cover several focus areas, including clinical improvement, revenue and cost enhancement, ambulatory operations, regulatory measures and registries, and data management. In addition to software, the company delivers implementation support, data science consulting, and tech-enabled managed services. Health Catalyst primarily serves healthcare providers and related organizations, including integrated delivery networks, academic medical centers, community hospitals, physician practices, accountable care organizations, health insurers, and health information exchanges.
Company profile, executives and historyHealth Catalyst stock: common questions
What is Health Catalyst's stock price?
HCAT closed at $1.36 on Nov 12, 2026, down 4.90% on the day. Over the past 52 weeks it traded between $0.96 and $3.02.
What is Health Catalyst's market cap?
Health Catalyst was worth $102.35M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is HCAT's P/E ratio?
Health Catalyst lost money over the twelve months to Sep 30, 2026 (diluted EPS -$2.83), so it has no meaningful P/E ratio.
How much revenue does Health Catalyst make?
Health Catalyst reported revenue of $272.21M for the twelve months to Sep 30, 2026, down 13.9% from a year earlier.
Does Health Catalyst pay a dividend?
No. Health Catalyst has not paid a cash dividend over the last twelve months.
When does Health Catalyst report earnings next?
Health Catalyst is expected to report Q4 FY2026 results on Mar 11, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has HCAT stock performed over the past year?
Including dividends, HCAT returned -44.7% over the past year, against +12.0% for the S&P 500.
How many HCAT shares are sold short?
2M shares were sold short at the latest FINRA report, 4.17% of the float, or 7.2 days of average trading volume.
Who are Health Catalyst's competitors?
Companies most similar to Health Catalyst by business, industry and size include HSTM, DH, SMWB, ALYAF, INOD.
See a number that looks wrong?